Page last updated: 2024-09-05

razaxaban and rivaroxaban

razaxaban has been researched along with rivaroxaban in 2 studies

Compound Research Comparison

Studies
(razaxaban)
Trials
(razaxaban)
Recent Studies (post-2010)
(razaxaban)
Studies
(rivaroxaban)
Trials
(rivaroxaban)
Recent Studies (post-2010) (rivaroxaban)
20024,7415694,357

Protein Interaction Comparison

ProteinTaxonomyrazaxaban (IC50)rivaroxaban (IC50)
Coagulation factor XHomo sapiens (human)0.0038

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheney, DL; Knabb, RM; Pinto, DJ; Smallheer, JM; Wexler, RR1
Barrett, YC; Frost, C; Shenker, A; Wang, Z1

Reviews

1 review(s) available for razaxaban and rivaroxaban

ArticleYear
Factor Xa inhibitors: next-generation antithrombotic agents.
    Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17

    Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis

2010

Other Studies

1 other study(ies) available for razaxaban and rivaroxaban

ArticleYear
Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:6

    Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Factor Xa Inhibitors; Humans; International Normalized Ratio; Isoxazoles; Morpholines; Predictive Value of Tests; Prothrombin Time; Pyrazoles; Pyridones; Reproducibility of Results; Rivaroxaban; Thiophenes; Venous Thromboembolism

2010